Axiom Bio
United States · Founded 2023 · $15.0M raised
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- axi.om
- Total Funding
- $15.0M
- Last Round
- $15.0M SeedApr 2025
- Rounds
- 1
About
AI-powered biotech company building translational intelligence to replace animal testing and predict human drug toxicity.
Summary
Axiom Bio is an Artificial Intelligence company based in United States, founded in 2023. It has raised $15.0M in total across 1 round, most recently a $15.0M Seed round in Apr 2025. Investors include Amplify Partners, Dimension Capital and Zetta Venture Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2025
Investors
.png){kind=avatar}
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...